10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2016

Filing Information

Form Type	10-K
Accession Number	`0001493152-17-003242`
Period End Date	20161231
Filing Date	20170331
Fiscal Year	2016
Fiscal Period	FY
XBRL Instance	heb-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 57 Cash Flow Statement 80 Stockholders Equity 22

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$3.46M	USD	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$6.79M	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Work-In-Process inventory	`InventoryWorkInProcess`	-	USD	Point-in-time
Work-In-Process inventory	`InventoryWorkInProcess`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Work-In-Process inventory	`InventoryWorkInProcess`	$1.33M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	20.63M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	24.20M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$309.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$335.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.57M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	20.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	24.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.24M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.51M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$872.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$862.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Total assets	`Assets`	$22.80M	USD	Point-in-time
Total assets	`Assets`	$18.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$887.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.22M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$1.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$940.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	-	USD	Point-in-time
Commitments and contingencies (Notes 9,11,12,14 and 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 9,11,12,14 and 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 24,202,921 and 20,629,957, respectively	`CommonStockValue`	$24.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 24,202,921 and 20,629,957, respectively	`CommonStockValue`	$21.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$315.98M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$313.45M	USD	Point-in-time
Other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-5.00K	USD	Point-in-time
Other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-97.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-293.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-300.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$29.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.37M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$25.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.80M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$18.87M	USD	Point-in-time

Income Statement 57 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`HealthCareOrganizationRevenue`	$133.00K	USD	Annual
Clinical treatment programs	`HealthCareOrganizationRevenue`	$92.00K	USD	Annual
Clinical treatment programs	`HealthCareOrganizationRevenue`	$197.00K	USD	Annual
Total Revenues	`SalesRevenueNet`	$197.00K	USD	Annual
Total Revenues	`SalesRevenueNet`	$133.00K	USD	Annual
Total Revenues	`SalesRevenueNet`	$92.00K	USD	Annual
Production costs	`ManufacturingCosts`	$1.11M	USD	Annual
Production costs	`ManufacturingCosts`	$1.25M	USD	Annual
Production costs	`ManufacturingCosts`	$1.60M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.04M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.99M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.11M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.15M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$9.06M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.68M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$19.30M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$16.78M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$13.90M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-19.10M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-16.65M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-13.80M	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$364.00K	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$665.00K	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$129.00K	USD	Annual
Impairment loss on investments	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$315.00K	USD	Annual
Impairment loss on investments	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	-	USD	Annual
Impairment loss on investments	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$145.00K	USD	Annual
Interest expense	`InterestExpense`	$11.00K	USD	Annual
Interest expense	`InterestExpense`	$3.00K	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Litigation settlement net insurance proceeds	`ProceedsFromInsuranceSettlementInvestingActivities`	$-1.63M	USD	Annual
Litigation settlement net insurance proceeds	`ProceedsFromInsuranceSettlementInvestingActivities`	-	USD	Annual
Litigation settlement net insurance proceeds	`ProceedsFromInsuranceSettlementInvestingActivities`	-	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.37M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.13M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-2.87M	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-14.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.68M	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-7.50M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.45M	USD	Annual
Unrealized gain (loss) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$35.00K	USD	Annual
Unrealized gain (loss) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-191.00K	USD	Annual
Unrealized gain (loss) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-252.00K	USD	Annual
Reclassification adjustments for realized loss on sales of short-term marketable securities and for impairment losses on investments included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$57.00K	USD	Annual
Reclassification adjustments for realized loss on sales of short-term marketable securities and for impairment losses on investments included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$315.00K	USD	Annual
Reclassification adjustments for realized loss on sales of short-term marketable securities and for impairment losses on investments included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$145.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.50M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.41M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.17M	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-1.11	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.77	USD	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.69M	shares	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.68M	shares	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.82M	shares	Annual

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.50M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.45M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$665.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$941.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$1.12M	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$477.00K	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$249.00K	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$184.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-14.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.68M	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Equity-based compensation	`StockOptionPlanExpense`	$326.00K	USD	Annual
Equity-based compensation	`StockOptionPlanExpense`	$181.00K	USD	Annual
Equity-based compensation	`StockOptionPlanExpense`	$410.00K	USD	Annual
Other-than-temporary impairment of marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$315.00K	USD	Annual
Other-than-temporary impairment of marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	-	USD	Annual
Other-than-temporary impairment of marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$145.00K	USD	Annual
Realized gain (loss) on securities	`MarketableSecuritiesRealizedGainLoss`	$-63.00K	USD	Annual
Realized gain (loss) on securities	`MarketableSecuritiesRealizedGainLoss`	$-57.00K	USD	Annual
Realized gain (loss) on securities	`MarketableSecuritiesRealizedGainLoss`	$46.00K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.33M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	-	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	-	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-64.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$41.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-26.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-869.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-326.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-196.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.10M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$329.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.11M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.05M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.96M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.38M	USD	Annual
Purchases of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$504.00K	USD	Annual
Purchases of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$160.00K	USD	Annual
Purchases of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$240.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$258.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$250.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$294.00K	USD	Annual
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.29M	USD	Annual
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.37M	USD	Annual
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.84M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$6.35M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.92M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.53M	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.68M	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$4.74M	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$12.82M	USD	Annual
Deposits on capital leases refunded	`ProceedsFromPaymentsForDepositsAppliedToDebtRetirements`	-	USD	Annual
Deposits on capital leases refunded	`ProceedsFromPaymentsForDepositsAppliedToDebtRetirements`	$14.00K	USD	Annual
Deposits on capital leases refunded	`ProceedsFromPaymentsForDepositsAppliedToDebtRetirements`	$2.00K	USD	Annual
Payments on capital leases	`PaymentsOnCapitalLeases`	$21.00K	USD	Annual
Payments on capital leases	`PaymentsOnCapitalLeases`	$1.00K	USD	Annual
Payments on capital leases	`PaymentsOnCapitalLeases`	$34.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.79M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.66M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.76M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-41.00K	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.35M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$293.00K	USD	Annual
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`StockIssued1`	$59.00K	USD	Annual
Issuance of common stock for accounts payable and accrued expenses	`StockIssued1`	$672.00K	USD	Annual
Issuance of common stock for accounts payable and accrued expenses	`StockIssued1`	-	USD	Annual
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$-46.00K	USD	Annual
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$63.00K	USD	Annual
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$92.00K	USD	Annual
Cash paid for interest expense	`InterestPaid`	-	USD	Annual
Cash paid for interest expense	`InterestPaid`	$-3.00K	USD	Annual
Cash paid for interest expense	`InterestPaid`	$-11.00K	USD	Annual

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$25.00M	USD	Point-in-time
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time
Settlement of accounts payable	`StockIssuedDuringPeriodValueSettlementOfAccountsPayable`	$59.00K	USD	Annual
Settlement of accounts payable	`StockIssuedDuringPeriodValueSettlementOfAccountsPayable`	$672.00K	USD	Annual
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$174.00K	USD	Annual
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$12.82M	USD	Annual
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$9.68M	USD	Annual
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$181.00K	USD	Annual
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$410.00K	USD	Annual
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$326.00K	USD	Annual
Common stock issuance	`StockIssuedDuringPeriodValueNewIssues1`	$4.52M	USD	Annual
Other issuances	`StockIssuedDuringPeriodValueOther`	$50.00K	USD	Annual
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.62M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.50M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.41M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.17M	USD	Annual
Balance	`StockholdersEquity`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$25.00M	USD	Point-in-time
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.